Klin Padiatr 2025; 237(03): 176-177
DOI: 10.1055/s-0045-1808991
Abstracts

Deciphering the role of non-coding sequence variants predisposing to pediatric B-ALL

S Wittibschlager
1   St. Anna Children’s Cancer Research Institute (CCRI), Vienna, Austria
2   CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna, Austria
,
A P Kutschat
1   St. Anna Children’s Cancer Research Institute (CCRI), Vienna, Austria
2   CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna, Austria
,
Z M Patel
3   Broad Institute of MIT and Harvard, Cambridge, USA
4   Massachusetts General Hospital Research Institute, Boston, USA
5   Harvard Medical School, Boston, USA
,
B Becerra
3   Broad Institute of MIT and Harvard, Cambridge, USA
4   Massachusetts General Hospital Research Institute, Boston, USA
5   Harvard Medical School, Boston, USA
,
D E Bauer
3   Broad Institute of MIT and Harvard, Cambridge, USA
5   Harvard Medical School, Boston, USA
,
L Pinello
3   Broad Institute of MIT and Harvard, Cambridge, USA
4   Massachusetts General Hospital Research Institute, Boston, USA
5   Harvard Medical School, Boston, USA
,
D Seruggia
1   St. Anna Children’s Cancer Research Institute (CCRI), Vienna, Austria
2   CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna, Austria
› Author Affiliations
 

Most trait- and disease-associated sequence variants map at non-coding regions, modulating transcription factor (TF) binding and transcription of the associated gene. Multiple genome-wide association studies linked several non-coding germline variants to increased risk of pediatric B-ALL, particularly at the IKZF1 locus. However, the consequence of intergenic variants at IKZF1 and the mechanism of disease predisposition remain largely unknown. Here, we established IKZF1-GFP reporter NALM6 and REH cell lines and a multi-scale screening approach to map the regulatory network of IKZF1, identify top regulators, and elucidate the effect of disease-associated variants at TF binding motifs. To uncover putative cis-regulatory elements, we applied a CRISPRi screen tiling ~400kb at the IKZF1 locus, including its promoter, 3’ UTR, proximal and distal enhancers. In this screen, we identified two distal enhancers as well as a cis-regulatory sequence located at the IKZF1 3’ UTR. In parallel, to identify trans-regulators of IKZF1, we performed a KO screen, targeting 635 TFs expressed in the hematopoietic lineage, and identified a shortlist of high-confidence IKZF1 regulators.



Publication History

Article published online:
09 May 2025

© 2025. Thieme. All rights reserved.

Georg Thieme Verlag KG
Oswald-Hesse-Straße 50, 70469 Stuttgart, Germany